Alector Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Alector has a total shareholder equity of $150.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $570.7M and $420.2M respectively.
Anahtar bilgiler
0%
Borç/özkaynak oranı
US$0
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$503.33m |
| Eşitlik | US$150.57m |
| Toplam yükümlülükler | US$420.16m |
| Toplam varlıklar | US$570.73m |
Son finansal sağlık güncellemeleri
We Think Alector (NASDAQ:ALEC) Needs To Drive Business Growth Carefully
Sep 26
Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Sep 25Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Jun 27Alector (NASDAQ:ALEC) Is In A Good Position To Deliver On Growth Plans
Jan 16Recent updates
Alector, Inc.'s (NASDAQ:ALEC) Business And Shares Still Trailing The Industry
Oct 24We Think Alector (NASDAQ:ALEC) Needs To Drive Business Growth Carefully
Sep 26Alector, Inc.'s (NASDAQ:ALEC) Price Is Right But Growth Is Lacking
Jul 11Alector, Inc. (NASDAQ:ALEC) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 11Analysts Are Updating Their Alector, Inc. (NASDAQ:ALEC) Estimates After Its Full-Year Results
Mar 01The Market Doesn't Like What It Sees From Alector, Inc.'s (NASDAQ:ALEC) Revenues Yet As Shares Tumble 27%
Jan 19Alector: Good Data, Huge Cash, No Near Term Catalyst
Jan 16Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Sep 25Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Jun 27Analysts Are Betting On Alector, Inc. (NASDAQ:ALEC) With A Big Upgrade This Week
Mar 02Alector (NASDAQ:ALEC) Is In A Good Position To Deliver On Growth Plans
Jan 16Alector: Advancement Of Third Alzheimer's Drug Brings About Huge Potential
Oct 04AbbVie ends partnership with Alector for Alzheimer’s candidate
Jul 08Alector: Potential In Neurology And Cancer Treatments
Jun 14Need To Know: The Consensus Just Cut Its Alector, Inc. (NASDAQ:ALEC) Estimates For 2022
May 18Alector: Expect Phase 3 Data Next Year
Apr 16These Analysts Just Made An Downgrade To Their Alector, Inc. (NASDAQ:ALEC) EPS Forecasts
Feb 27Alector, Inc: A Newer Biotech Company With Big Potential
Jan 26Alector: The GSK Deal Is A Major Value Add
Oct 29Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: ALEC's short term assets ($519.7M) exceed its short term liabilities ($147.7M).
Uzun Vadeli Yükümlülükler: ALEC's short term assets ($519.7M) exceed its long term liabilities ($272.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: ALEC is debt free.
Borcun Azaltılması: ALEC has not had any debt for past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: ALEC has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: ALEC has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 11.8% each year.